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PCardiac Imaging
Noninvasive Evaluation With Multislice Computed
Tomography in Suspected Acute Coronary Syndrome
Plaque Morphology on Multislice Computed
Tomography Versus Coronary Calcium Score
Maureen M. Henneman, MD,* Joanne D. Schuijf, PHD,*† Gabija Pundziute, MD,*
Jacob M. van Werkhoven, MSC,* Ernst E. van der Wall, MD, PHD,*† J. Wouter Jukema, MD, PHD,*†
Jeroen J. Bax, MD, PHD*
Leiden and Utrecht, the Netherlands
Objectives Our aim was to evaluate the atherosclerotic plaque burden and morphology as determined by 64-slice multislice
computed tomography (MSCT) coronary angiography in relation to the calcium score in patients presenting with
suspected acute coronary syndrome (ACS).
Background The absence of coronary calcium during coronary calcium scoring has been proposed to rule out significant coro-
nary artery disease (CAD). However, data in patients presenting with suspected ACS are scarce.
Methods In 40 patients (age 57  11 years, 26 men) presenting with suspected ACS, MSCT coronary angiography in com-
bination with coronary calcium scoring was performed before conventional coronary angiography. MSCT angio-
grams were evaluated for the presence or absence of coronary atherosclerotic plaque and the presence or ab-
sence of obstructive (50% luminal narrowing) CAD. In addition, plaque type was determined, and findings were
related to the calcium score.
Results Coronary artery disease was observed in 38 patients, of whom 10 patients had nonobstructive and 28 patients
had obstructive CAD, confirmed by conventional coronary angiography in all patients. In patients with CAD,
plaques were distributed as follows: 39% noncalcified plaques, 47% mixed plaques, and 14% calcified plaques.
Coronary calcium was detected in 27 patients, of whom 10 had a score 400. In 13 (33%) patients, no coro-
nary calcium was observed, but in 11 (85%), atherosclerotic plaques were detected on MSCT angiography.
Conclusions In patients presenting with suspected ACS, noncalcified plaques are highly prevalent and the absence of coro-
nary calcium does not reliably exclude the presence of (significant) atherosclerosis. This information may be of
value to improve our understanding of the potential role of MSCT in this patient population. (J Am Coll Cardiol
2008;52:216–22) © 2008 by the American College of Cardiology Foundation













Aoronary artery calcium score (CS) has been demonstrated to
ave an excellent prognostic value in asymptomatic individuals
1). A very low rate of cardiac death and myocardial infarction
0.4%) over 3 to 5 years has been reported for individuals
ithout detectable calcium. In contrast, event rates as high as
.1% have been reported for individuals with extensive calcium,
eflected by a CS 1,000 (1). The positive relationship
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ccepted April 15, 2008.etween a high CS and an elevated cardiac event rate may be
xplained by the fact that an increase in coronary calcium
eflects an increase in overall coronary plaque burden. How-
ver, the presence of coronary calcium is considered to repre-
ent a more advanced and stable stage of atherosclerosis, and
oncalcified plaque burden, which may represent the more
nitial stages of atherosclerotic disease, is not appreciated with
alcium scoring. Moreover, preliminary data in patients with
cute coronary syndrome (ACS) suggest a larger contribution
f noncalcified plaques to the overall plaque burden compared
ith that in patients with stable coronary artery disease (CAD)
2,3). As a consequence, a low CS may significantly underes-
imate the overall coronary plaque burden in the setting of
CS.
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July 15, 2008:216–22 MSCT in Suspected ACSoninvasive evaluation of the coronary arteries. With this
echnique, the coronary arteries are directly visualized; not
nly the degree of atherosclerosis but also the degree of
tenosis can be evaluated with high accuracy (4). Accord-
ngly, the technique may be of interest in the diagnostic
ork-up of patients presenting with suspected ACS in the
mergency department (5). A particular advantage is the
act that noncalcified atherosclerosis is also identified, thus
roviding a more accurate evaluation of the underlying
therosclerotic plaque burden. However, this is at the cost of
ontrast administration and a higher radiation dose. At
resent, data on how the CS relates to observations obtained
ith MSCT coronary angiography in patients presenting
ith suspected ACS are scarce.
The aim of the present study, therefore, was to assess the
resence of coronary calcium in patients with suspected
CS, and to evaluate the overall atherosclerotic burden and
laque morphology in relation to the CS.
ethods
tudy population. Forty consecutive patients who were
dmitted in our hospital with suspected ACS were included
n the study. All patients underwent noninvasive coronary
ngiography with MSCT to evaluate the presence or ab-
ence of obstructive (50% luminal narrowing) CAD,
efore conventional invasive coronary angiography was per-
ormed. Both investigations were performed within 24 h of
ach other. Patients presenting with ST-segment elevation
yocardial infarction were not included and were directly
eferred to conventional coronary angiography. However,
atients with other electrocardiographic (ECG) changes
ere enrolled. Contraindications to MSCT included known
llergy to iodine contrast media (supra)ventricular arrhyth-
ias and renal insufficiency (serum creatinine 120 mmol/l).
SCT was performed within the clinical diagnostic
ork-up of patients, and the results presented are observa-
ional findings.
SCT, data acquisition. MSCT examinations were per-
ormed with a 64-slice Toshiba multislice Aquilion 64
ystem (Toshiba Medical Systems, Otawara, Japan). In all
atients, a noncontrast enhanced scan was performed before
SCT angiography to assess the total coronary calcium
urden. Collimation was 4 3.0 mm and rotation time 500
s. Tube current and voltage were 200 mA and 120 kV.
For the contrast-enhanced scan, collimation was 64 0.5
m and rotation time was 400 or 450 ms, depending on
eart rate. Tube current and voltage were 300 mA (range
50 to 400 mA) and 120 kV (range 100 to 135 kV),
espectively. Total amount of contrast (Iomeron 400, Al-
ana, Konstanz, Germany) was 90 to 110 ml, followed by a
aline flush of 50 ml, both injected at 5 ml/s. Automated
etection of peak enhancement in the aortic root was used
o time the scan. In all patients, imaging was performed
uring an inspiratory breath hold and electrographic gating.
n patients with a heart rate 65 beats/min, beta-blocking agents were administered before
SCT imaging if no contrain-
ications for beta-blockade were
resent. No additional nitroglyc-
rin was given for MSCT imag-
ng. Although no ECG X-ray
odulation was applied, care was
aken to minimize radiation dose
y using lower kV and mA values
n patients with either normal or
mall posture. The average radi-
tion dose for MSCT was 15.6
o 16.2 mSv.
SCT, data analysis. CORO -
ARY ARTERY CS. All data were
valuated on a remote workstation using dedicated software
Vitrea 2, Vital Images, Plymouth, Minnesota). In each
atient, coronary calcium was identified as a dense area in
he coronary artery exceeding the threshold of 130 HUs,
nd the total CS was calculated based on Agatston (6).
ORONARY ANGIOGRAPHY. In all patients, the complete
oronary arterial tree was assessed for the presence of coronary
laques (regardless of their severity) by 2 experienced
bservers, by consensus. Segments with previously im-
lanted stents were excluded from the analysis. The location
f each plaque was documented according to the segmen-
ation model of the American Heart Association/American
ollege of Cardiology (7), and 1 coronary plaque was
ssigned per coronary segment. Each plaque was subse-
uently visually classified as obstructive or nonobstructive
sing a 50% threshold of luminal narrowing. For each
atient, the total number of diseased coronary segments
segments containing plaques) and the number of coronary
egments with nonobstructive as well as obstructive plaques
ere determined.
LAQUE MORPHOLOGY. Subsequently, each interpretable
laque was classified as follows: 1) calcified plaque plaque
ith a high density compared with the contrast-enhanced
essel lumen; 2) mixed plaque  plaque with noncalcified
nd calcified elements within a single plaque; or 3) noncal-
ified plaque  plaque having a lower density compared
ith the contrast-enhanced vessel lumen.
ONVENTIONAL CORONARY ANGIOGRAPHY. Conventional
oronary angiography was performed according to the
tandard techniques. To obtain vascular access, the femoral
pproach with the Seldinger technique was used. An expe-
ienced observer blinded to the MSCT data performed a
isual evaluation of the coronary angiograms. Coronary
rteries were divided in 17 segments according to the
uidelines of the American Heart Association/American
ollege of Cardiology (7). Obstructive CAD was defined as
50% luminal narrowing of 1 coronary segment. In
Abbreviations
and Acronyms
ACS  acute coronary
syndrome
CABG  coronary artery
bypass graft surgery
CAD  coronary artery
disease
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MSCT in Suspected ACS July 15, 2008:216–22onsidered as having single-vessel or multivessel CAD as
ppropriate.
Finally, based on electrocardiographic findings, left ven-
ricular wall motion abnormalities, angiographic lesion mor-
hology, and revascularization strategy, culprit lesions were
dentified.
tatistical analysis. Results are presented as mean values
D. Categorical data were compared with the chi-square
est. Finally, the prevalence of the different coronary CS was
ompared with the presence of (non)obstructive CAD. A
value 0.05 was considered as statistically significant.
esults
tudy population. In total, 40 consecutive patients (26
en, age 57 11 years) with suspected ACS were included
n this study. The baseline characteristics of the patients are
ummarized in Table 1. All patients presented to the
mergency department with suspected ACS. The majority
f patients were diagnosed as having an intermediate risk of
CS (Thrombolysis In Myocardial Infarction [TIMI]
II: 12 [30%] and TIMI IV: 9 [23%]), whereas 18
atients were classified as having a low risk of ACS
TIMI I: 9 [23%] and TIMI II: 9 [23%]) (8). Only 1
atient had a high risk of ACS (TIMI V: 1 [2%]). In
otal, 6 patients with positive enzymes were included of
hom 3 patients had no abnormalities on their ECG,
hereas 3 patients presented with negative T waves on
heir ECG. An additional 2 patients showed positive
roponin values during serial testing after MSCT. In total,
1 (28%) patients presented with previous percutaneous
oronary intervention (PCI) (in 9 patients in combination
ith stent implantation). The diagnosis of ACS was con-
aseline Characteristics of the Study Population
Table 1 Baseline Characteristics of the Study Population
Number of patients 40
Gender (M/F) 26/14
Age (yrs) 57  11
Risk factors for CAD
Average body mass index (kg/m2) 27  3
Diabetes mellitus 6 (15%)
Hypertension 20 (50%)
Hypercholesterolemia 18 (45%)
Family history of CAD 17 (43%)
Current smoking 19 (48%)
History
Previous PCI 11 (28%)
Previous MI 10 (25%)
(Non)obstructive CAD as observed on CAG*
Nonobstructive CAD 10 (25%)
Single-vessel CAD 12 (30%)
Multiple-vessel CAD 16 (40%)
Average number of segments with significant stenoses 1.6  1.8
Average number of segments with any atherosclerotic plaques 5.6  3.4
In 2 patients, no coronary plaques could be demonstrated.m
CAD  coronary artery disease; CAG  conventional coronary angiography; MI  myocardial
nfarction; PCI  percutaneous coronary intervention.rmed by coronary angiography in 25 patients. Single- and
ultivessel disease (based on the presence of a significant
tenosis or previous PCI in the corresponding coronary
rtery) was observed in 12 and 16 patients, respectively. PCI
as performed in 17 patients whereas 4 patients were
eferred for coronary artery bypass grafting (CABG). The
emaining 4 patients were treated conservatively.
oronary artery CS. In all 40 patients, the coronary CS
ould be obtained. In 13 (33%) patients, coronary calcium
as absent. Coronary calcium was detected in 27 patients
67%), in whom 10 (37%) there was a score 400. A CS of
to 9 was shown in 3 (8%) patients, whereas CS was 10 to
00 in 8 (20%) patients. In 6 (15%) patients, CS was 101 to
00, and in 10 (25%) patients a CS 400 was identified.
SCT coronary angiography. LESION CHARACTERIS-
ICS. On a segmental basis, a total of 565 coronary seg-
ents were available for analysis after exclusion of 10
egments due to previous coronary stenting.
In the remaining segments, coronary plaques were iden-
ified in 224 (40%) segments. Lesions were nonobstructive
50% luminal narrowing) in 159 (71%) segments, whereas
esions were deemed obstructive in 65 (29%) segments.
oncalcified plaque was identified in 87 (39%) of the 224
iseased coronary segments on MSCT. In 105 (47%)
iseased segments, mixed plaque was observed, whereas
alcified plaque was present in 32 (14%) segments (Fig. 1).
n total, 36 culprit lesions were identified. In these lesions,
laque morphology was noncalcified in 18 (50%), mixed in
6 (44%), whereas only 2 (6%) lesions were calcified.
ATIENT CHARACTERISTICS. In 2 (5%) patients, complete
bsence of coronary plaques was demonstrated on MSCT.
onobstructive CAD was observed in 10 (25%) and obstruc-
ive CAD was present in 28 (70%) patients, respectively.
In 12 (30%) patients, single-vessel disease was demon-
trated, whereas in 16 (40%) patients multivessel disease was
resent, confirmed by conventional coronary angiography in
ll patients.
Patients with multivessel disease presented with relatively
ore mixed (55%) and less noncalcified plaques (30%) as
ompared with patients with nonobstructive CAD and
atients with single-vessel CAD. However, the percentage
f calcified plaques remained fairly constant between the 3
roups (12% in nonobstructive CAD vs. 14% in single-
essel CAD vs. 15% in multivessel CAD). The relative
istribution of plaque types for patients with nonobstructive
AD, single-vessel CAD, and multivessel CAD is illus-
rated in Figure 2.
oronary CS versus the presence of significant stenosis
nd atherosclerotic plaque on MSCT angiography. In
igure 3, the relation between the presence of various
oronary CS and the presence of CAD is illustrated.
mportantly, in 5 (39%) of the 13 patients without coronary
alcium, obstructive CAD was present despite the absence
f any calcium. In all of these patients, revascularization by
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July 15, 2008:216–22 MSCT in Suspected ACSithout coronary artery calcium, but with obstructive CAD,
s provided in Figure 4.
Considering patients with elevated coronary CS, the
ajority showed obstructive CAD on MSCT; significant
tenosis was detected in 5 (83%) of the 6 patients with CS
01 to 400 and in 9 (90%) of the 10 patients with CS400.
ll of the patients with CS 101 to 400 and significant
tenosis underwent subsequent revascularization (3 patients
nderwent PCI and 2 patients underwent CABG). Of the
atients with CS 400 and significant stenosis, revascular-
zation was performed in 7 (78%) (PCI: n  5 patients,
ABG: n  2 patients). The remaining patients were
reated conservatively with optimal medical treatment.
Figure 1 Percentage of Segments With and Without
Plaque, and Prevalence of the Different Plaque Types
(Left) Percentage of segments with plaque (solid area) and segments without
plaque (open area). (Right) Prevalence of the different plaque types: noncalci-
fied plaque (open area), mixed plaque (hatched area), and calcified plaque
(solid area).
Figure 2 Presence of Different Plaque
Types in the Various Patient Groups
Patients with multivessel disease presented with relatively more mixed (55%)
and less noncalcified plaques (30%) as compared with patients with nonob-
structive coronary artery disease (CAD) and patients with single-vessel CAD.
The prevalence of calcified plaques remained constant between the 3 groups
(nonobstructive CAD: 12% vs. single-vessel CAD: 14% vs. multivessel CAD:
15%). Open bars  noncalcified plaques; hatched bars  mixed plaques; solid
bars  calcified plaques.iiscussion
he main finding of the present study is that a considerable
roportion of patients with suspected ACS present without
oronary calcium on MSCT. In 13 (33%) of the 40 patients
ith suspected ACS, no coronary calcium was observed.
owever, in 11 (85%) of these patients, coronary artery
laques could be observed, causing a significant stenosis in 5
39%) of these patients.
Indeed, in line with this observation, a high proportion
39% of total plaque burden) of noncalcified plaques was
resent in the whole study population. Even in multivessel
isease (which may reflect more advanced CAD) a large
roportion of the atherosclerotic plaques were still noncal-
ified with a similar amount of calcified plaques compared
ith that seen in patients with either nonobstructive CAD
r single-vessel disease.
In the last decade, the prognostic value of CS assessment
as been extensively investigated in mainly asymptomatic
ohorts. Indeed, Shaw et al. (9) demonstrated in a large
ohort of 10,377 asymptomatic patients who underwent
lectron-beam computed tomography for CS screening that
he 5-year risk-adjusted survival for patients with CS 10
as 99.0% compared with 95.0% for patients with CS
1,000 (9). It is widely accepted that the coronary CS is
elated to the total atherosclerotic burden and can, there-
ore, provide long-term prognostic information in asymp-
omatic patients (10).
However, in patients presenting with suspected ACS, the
oal is to establish the presence of significant stenoses as the
ause of acute chest pain. Accordingly, the CS may be less
eliable in this setting since the presence of coronary calcium
s not specific for obstructive CAD. Although a positive
elation exists between the amount of coronary calcium at a
ite and the severity of stenosis at that site, this relation is
onlinear (11). Moreover, noncalcified lesions are not de-
ected, potentially further limiting the use of calcium scor-
Figure 3 Presence of (Non)Obstructive CAD and the
Presence of Plaque for the Different CS Groups
Note that a calcium score (CS) of 0 in only 15% of patients corresponded with
complete absence of coronary artery disease (CAD), whereas 39% presented
with obstructive CAD. Open bar  normal; hatched bars  plaque with nonob-
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MSCT in Suspected ACS July 15, 2008:216–22Indeed, in ACS, there appears to be a tendency toward a
ower completely calcified plaque burden. In the present
tudy, only 14% of the plaques observed were calcified, with
6% of lesions containing noncalcified tissue. This finding is
n line with previous studies. Recently, similar findings were
eported by Schuijf et al. (2), who studied differences in
laque composition and distribution as assessed with
SCT in 46 patients presenting with ACS compared with
hat in patients with stable CAD. It was demonstrated that
n patients with stable CAD a significantly larger portion of
he plaques was calcified as compared with that seen in
atients presenting with ACS (p  0.001). Similarly,
offmann et al. (12) showed that in culprit lesions of
atients with ACS, noncalcified tissue was constantly
resent while none of the culprit lesions was exclusively
ormed by calcified plaque. In contrast, Mollet et al. (13)
howed that completely calcified plaques tend to be more
requently encountered in patients with stable CAD, with
alcified lesions contributing to 65% of the total plaque
urden. Similar results were found by Hausleiter et al. (14),
ho investigated plaque morphology in a stable population
onsisting of 161 patients with an intermediate risk for
ignificant CAD. The authors showed that the majority of
atients (98 [61%]) had calcified plaques. Importantly, even
n this cohort of patients with stable CAD and a high
revalence of calcified plaques, noncalcified plaques were
resent in 16% of patients without any coronary calcium.
In our study, we also explored the prevalence of the
ifferent plaque types among patients with nonobstructive







Figure 4 Example of a Patient Without Coronary Artery Calcium
This patient presented with suspected acute coronary syndrome. Multislice compu
fied plaque and superimposed thrombus was observed in the distal segment of th
struction. (C) Multiplanar reconstruction, arrow indicating obstructive coronary arte
conventional coronary angiography. (D) Conventional coronary angiography showin
artery; LCx  left circumflex coronary artery.ivessel CAD. A trend in plaque distribution between the 3 nroups was observed. Patients with obstructive multivessel
AD appeared to have less noncalcified plaques (30%) and
ore mixed plaques (55%) as compared with patients with
onobstructive CAD (50% and 38%, respectively) and
bstructive single-vessel CAD (52% and 34%, respectively).
his progression from completely noncalcified to partially
alcified could potentially be regarded as reflecting the
evelopment of atherosclerotic lesions over time. Interest-
ngly, although one could assume that patients with mul-
ivessel CAD would have more advanced disease and,
herefore, more completely calcified plaques, the percentage
f calcified plaques appeared to remain constant among the
groups (12% in nonobstructive CAD, 14% in obstructive
ingle-vessel CAD, and 15% in obstructive multivessel
AD). Accordingly, calcifications appear to contribute to
nly a relatively small portion of coronary plaque burden
ver the whole range from subclinical to more advanced
isease in ACS, indicating that mere CS is not sufficient for
diagnostic work-up in this population. Possibly, these
bservations may also have implications for the effectiveness
f antiatherosclerotic therapies. Of interest, Nicholls et al.
15) recently demonstrated that noncalcified plaque compo-
ents may be more susceptible to regression by medical
herapies that target atherosclerotic risk factors. In contrast,
alcified plaques were less likely to reduce in size in this
tudy. These observations suggest that assessment of coro-
ary calcium alone may not be optimal to identify patients
ikely to derive the greatest benefit from aggressive antiath-
rosclerotic treatment. Possibly, noninvasive coronary an-





mography showed no coronary artery calcium (A). However, obstructive noncalci-
coronary artery on multislice computed tomography. (B) Volume-rendered recon-
ease (CAD) in right coronary artery (RCA). This finding was confirmed by
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July 15, 2008:216–22 MSCT in Suspected ACSental value. Importantly, however, thus far no prospective
ata are available to support this hypothesis.
linical implications. In the current study, obstructive
AD was present in 11 (46%) of the 24 patients with low
S (CS 100). Similar findings have been reported by
ubinshtein et al. (16), who examined the extent of CAD,
sing 64-slice MSCT, in 231 (predominantly stable) pa-
ients with a zero or low (100) CS. In the patients without
etectable calcium (n  125), CAD was observed in 25
20%) patients, with obstructive lesions in 9 (36%). Expand-
ng the analysis to patients with low CS (defined as CS
100), significant CAD was observed in 18 (32%). Accord-
ngly, the authors concluded that the absence of coronary
alcium or a low CS in symptomatic patients does not
eliably exclude (significant) CAD (16). The precise role of
SCT in patients presenting with suspected ACS is at
resent still unclear. However, our study shows that these
atients frequently present with noncalcified plaques. Ac-
ordingly, it appears that MSCT coronary angiography
rovides more information as compared with calcium scor-
ng and may be preferred. Evidently, the use of MSCT in
he setting of suspected ACS needs further study, although
he recently published appropriateness criteria have indi-
ated that MSCT may provide a suitable alternative in
atients with low-to-intermediate pre-test likelihood of
CS (17).
Indeed, as Hoffmann et al. (18) recently showed, nonin-
asive assessment of coronary anatomy by MSCT may be of
se in the triage of patients presenting with acute chest pain
n the emergency department. In 89 patients, ACS was
uled out by standard clinical care, whereas 14 patients were
iagnosed with ACS. High negative predictive values of
00% for both the absence of significant stenosis and for the
bsence of coronary atherosclerotic plaque were demon-
trated. Similar observations have been reported recently by
ther groups (5,19,20). Accordingly, MSCT may have the
otential to facilitate early discharge of patients with acute
hest pain but with inconclusive evaluation (18).
tudy limitations. Several limitations need to be ad-
ressed. First, the patient population described in this study
s relatively small, and the results will need to be confirmed
n larger populations of symptomatic patients. Also, only
onventional coronary angiography was performed, and no
omparison between MSCT and intravascular ultrasound
as available for the classification of noncalcified, mixed,
nd calcified plaque. However, this was not the purpose of
he present study; previous studies have demonstrated that
lassification of plaque type into noncalcified, mixed, and
alcified with MSCT is both accurate and reproducible
21–23).
Finally, more general limitations inherent to MSCT need
o be mentioned. The radiation burden of MSCT is still
igh, and, at the moment, the technique remains limited to
atients with low heart rate, making administration of
eta-blocking agents necessary before MSCT (24). How-
ver, administration of beta-blocking agents is part of thereatment of ACS in general, and the need for heart rate
ontrol is, therefore, not an important limitation in this
atient population. In this study, the average radiation dose
or MSCT was 15.6 to 16.2 mSv. Accordingly, the currently
sed protocol still required a substantial radiation dose.
articularly in younger female patients, use of MSCT
hould be treated with caution due to a higher lifetime
ancer risk, as recently emphasized by Einstein et al. (25).
xtensive effort, therefore, is currently invested in the
evelopment of dose-reduction protocols. Recently, Hus-
ann et al. (26) described the feasibility of low-dose
omputed tomographic angiography with prospective ECG
ating. In this study, the authors were able to obtain good
mage quality at an average dose of 1.1 to 3.0 mSv. Other
evelopments include the introduction of 320-slice com-
uted tomographic angiography, which allows prospective
mage acquisition without any overlap in a single rotation
27). Accordingly, substantial dose reduction may be
chieved in the near future using novel acquisition protocols.
Finally, due to blooming artifacts, diagnostic accuracy of
SCT imaging is currently limited in patients with severe
oronary calcifications and previous coronary stenting.
onclusions
n patients presenting with acute chest pain, noncalcified
laques are highly prevalent. As a result, the absence of
oronary calcium does not reliably exclude the presence of
therosclerosis or even obstructive CAD. This information
ay be of value to improve our understanding of the
otential role of MSCT in this patient population.
eprint requests and correspondence: Dr. Jeroen J. Bax, Depart-
ent of Cardiology, Leiden University Medical Center, Albinus-
reef 2, 2333 ZA Leiden, the Netherlands. E-mail: j.j.bax@
umc.nl.
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